Premier Health of America Announces Anticipated Delay in Filing Interim Financial Statements and Application for Management Cease Trade Order

The most recent release (June 2, 2026) announces that Premier Health will not file its Q1 2026 financial statements and MD&A by the June 1 regulatory deadline. The company blames “ongoing negotiations with the company’s lenders regarding a new forbearance agreement,” which are blocking the completion of required accounting and disclosure assessments. A Management Cease‑Trade Order (MCTO) has been applied for; if granted, it will prohibit trading by the Interim CEO, Interim CFO, and all directors, but will not affect public trading. Bi‑weekly default status reports will be issued during the MCTO period.

The announcement follows just three weeks after the termination of all existing forbearance agreements with principal lenders (May 8), confirming that the company remains in default of financial ratios under its credit agreements. In February, Q1 2026 results showed revenue down 44% year‑over‑year to C$17.8 million, Adjusted EBITDA collapsing to C$5 thousand, and a net loss of C$2.55 million. The company had already abandoned its Per Diem and transportation segments, refocusing solely on travel‑nurse services.

This is a clear negative development. The delay in filing is not a routine administrative hiccup; it is the direct consequence of a lender standoff that threatens the company’s ability to continue as a going concern. The sequence of events – financial‑ratio default, termination of forbearance, and now a filing delay – signals that Premier Health cannot produce reliable financial statements without first resolving its debt crisis. The MCTO, while technically a regulatory mechanism, further damages management credibility and underscores the precariousness of the company’s position.

The net‑loss trajectory (C$2.55 million in Q1 2026, C$6.5 million in Q4 2025), negative equity of C$13.8 million, and only C$92 thousand in cash against C$43.3 million of total debt leave almost no margin for error. The 12% revenue hit from Quebec public‑contract ineligibility (October 2025) continues to compound the distress. The market has already priced in near‑zero equity value; today’s announcement confirms that the risk of a worse outcome – recapitalization, bankruptcy, or liquidation – has increased materially. Therefore, this news is material‑negative.

Premier Health of America provides healthcare staffing services across Canada. After discontinuing Per Diem and transportation segments in Q1 2026, its sole remaining operation is travel‑nurse services. The company operates subsidiaries in Quebec (deemed ineligible for public contracts until ~2030) and other provinces. There is no flagship “project”; the business is a service‑based staffing model heavily dependent on provincial health‑authority contracts.